Federation Des Caisses Desjardins Du Quebec Essa Pharma Inc. Transaction History
Federation Des Caisses Desjardins Du Quebec
- $18.4 Billion
- Q4 2024
A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Essa Pharma Inc. stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 4,050 shares of EPIX stock, worth $7,087. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,050
Previous 4,050
-0.0%
Holding current value
$7,087
Previous $24,000
70.83%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding EPIX
# of Institutions
41Shares Held
40.6MCall Options Held
15.8KPut Options Held
21K-
Bvf Inc San Francisco, CA8.75MShares$15.3 Million1.69% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.88MShares$13.8 Million0.8% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT4.29MShares$7.5 Million2.21% of portfolio
-
Bml Capital Management, LLC Zionsville, IN4.22MShares$7.39 Million4.69% of portfolio
-
Morgan Stanley New York, NY4.18MShares$7.32 Million0.0% of portfolio
About ESSA Pharma Inc.
- Ticker EPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 44,073,100
- Market Cap $77.1M
- Description
- ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...